Caffeine and hair loss: the honest split — what topical caffeine does, what drinking it does, and why they are completely different questions.
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
0:00
|
6:49
From Root to Ritual by Laritelle Organic.
In brief: Two systematic reviews published in 2025 — one in the Journal of Drugs in Dermatology (Ly et al., November 2025, 9 studies including 5 RCTs) and one in Healthcare/MDPI (Szendzielorz & Spiewak, February 2025, 684 patients with GRADE assessment) — both found that topical caffeine consistently demonstrates hair growth benefit or reduced hair loss with minimal adverse effects. The honest cav...
Read the full article: https://laritelleorganic.com/blogs/from-root-to-ritual/caffeine-and-hair-loss-the-honest-split-what-topical-caffeine-does-what-drinking-it-does-and-why-they-are-completely-different-questions
SPEAKER_00
In brief, two systematic reviews published in 2025, one in the Journal of Drugs and Dermatology, Layat Al, November 2025, nine studies including five RCTs, and one in healthcare, /MDPI, Senzilers and Spiwak, February 2025, 684 patients with grade assessment. Both found that topical caffeine consistently demonstrates hair growth benefit or reduced hair loss with minimal adverse effects. The honest caveat: most of the evidence is rated low to very low quality by grade criteria. The evidence is almost entirely in men with AGA, and topical caffeine is not FDA approved for hair loss. Oral caffeine is a separate story, it blocks iron absorption and at high doses raises cortisol, neither of which helps hair. The caffeine and hair question is actually two different questions that require separate answers. Most articles about caffeine and hair conflate them, which is why the answer is confusing. The two questions are one, does applying caffeine topically to the scalp help hair growth? Promising, with genuine clinical evidence. 2. Does drinking coffee affect hair loss? Mostly negatively, through iron absorption and cortisol mechanisms. They involve the same molecule doing completely different things in completely different contexts. This article covers both. How does topical caffeine work for hair growth? Caffeine is hypothesized to provide hair-promoting effects by selective non-inhibition of 5-alpha reductus and phosphodiesterases, increasing intracellular cyclic adenosine monophoe, esphate, CAMP, and stimulating metabolic activity in hair follicles. The phosphodiesterase inhibition is the primary mechanism. Phosphodiesterase is the enzyme that breaks down cyclic AMP, CAMP, a signaling molecule that promotes cell proliferation and survival in hair follicle cells. DHT drives follicle miniaturization partly by reducing CAMP levels. Caffeine inhibits phosphodiesterase, which raises CAMP, which counteracts the DHT-driven miniaturization signal. This is a direct antiandrogenic mechanism at the cellular level, not through reducing DHT production or blocking the androgen receptor, but by counteracting its downstream effect on follicle cell metabolism. Caffeine also penetrates the hair follicle effectively when applied topically, a key pharmacokinetic advantage. Caffeine seems to be an effective agent against hair loss thanks to its stimulating effects on cell growth and good penetration into the hair follicle. This penetration means the active compound reaches the dermal papilla cells where the miniaturization process occurs rather than just coating the hair shaft. What do the 2025 systematic reviews actually show? The February 2025 systematic review published in Healthcare by Sen Zilers and Spiwak at Jagilonian University Medical College is the most rigorous assessment to date. The query returned 1,121 articles, of which nine ultimately met the inclusion criteria. In total, 684 people with androgenetic alopecia, excessive hair loss, or hair the inning were included. In all studies, conclusions were in favor of topical caffeine treatment. However, the level of scientific evidence was medium in three studies, low in one, and very low in the remaining five. The November 2025 Systematic Review in the Journal of Drugs and Dermatology, Layat Al, University of Minnesota, including Dr. Maria Hordinski, co-author of the wash frequency landmark study covered earlier in this series, found topical caffeine consistently demonstrated hair growth or reduced hair loss with minimal adverse effects. However, none of the studies use tattooed or marked scalp areas for hair counts. The methodology limitation, no permanent marking of scalp areas, means hair count comparisons between study visits are less precise than the gold standard would require. The conclusion from both reviews is the same. Caffeine appears to be a safe and promising potential treatment for hair loss. Topical caffeine shows potential as a therapeutic option, though further large-scale randomized controlled trials with standardized outcome measures are needed. 684 patients across nine clinical trials in the February 2025 MDPI systematic review. All studies found results in favor of topical caffeine, though most had low to very low grade evidence ratings, comparable to 5% monoxidal, the result from the best single RCT, comparing 0.2% topical caffeine solution to 5% monoxidal in men with AJ at 6 months. One study needs replication, 0.2%, 1%, the best studied concentrations, 0.2% for topical solutions and leave-on products, 1% for shampoo formulations, higher concentration needed for rinse-off contact time. What is the honest limitation of the topical caffeine evidence? The consistent positive results across all nine studies sound compelling. The grade evidence ratings tell the more complete story. A 2025 systematic review of clinical research on topical caffeine for hair loss examined multiple studies and found that most of them had a very low evidence rating. Caffeine was often tested as one ingredient within a 10 to 30 ingredient formula, making it impossible to isolate its individual contribution. Study durations were short, potentially not capturing a full hair growth cycle. Only two studies achieved a medium evidence rating, and even those had meaningful design limitations. The practical limitations for women specifically. Most of the clinical research on topical caffeine has been conducted in men with pattern hair loss. There is very little trial data on women with female pattern hair loss, on other types of hair loss, like alopecia areata or telogen effluvium, or on hair thinning caused by stress, nutrition, or medical treatments. The honest position Topical caffeine is a safe, biologically plausible, low risk adjunct intervention for androgenetic alopecia. With consistently positive clinical signals across all studies conducted, and with evidence quality that is not yet at the level of monoxidl or phenasteride, it falls under low rifox.